SILVER SPRING, Md., July 2, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease. “Alzheimer’s disease is a…